Informing patients about potential adverse drug reactions after percutaneous coronary intervention reduces the occurrence of self-reported adverse drug reactions

28 August 2022 (13:15 - 13:30)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Trond Roed Pettersen

Haukeland University Hospital, Bergen (Norway)

3 More presentations in this session

Presentation thumbnail

Clinical impact of improving sarcopenia through cardiac rehabilitation in patients with heart failure

Ms S. Shakuta (Sagamihara, JP)

Abstract Slides Video

Presentation thumbnail

End-of-life and palliative care provision to adults with congenital heart disease: mortality follow-back study using administrative data

Miss L. Van Bulck (Leuven, BE)

Abstract Slides Video

Presentation thumbnail

Sustained effect on diet quality of a self-care intervention to reduce cardiovascular disease risk among informal rural caregivers of people with chronic illnesses: does health literacy matter?

Doctor J. Kang (Lexington, US)

Abstract Slides Video

Access the full session

Session thumbnail

Nursing and Allied Professions Investigator Awards

The Event

Event poster

ESC Congress 2022

28 August 2022 13:15 CET

You may be interested in

Congress Presentation

Sex differences in incidence of self-reported adverse drug reactions after percutaneous coronary intervention

27 August 2023

Congress Session

Optimising cardiovascular care through multidisciplinary approaches and pharmacological strategies

31 August 2025

Congress Session

The guardians of clotting: exploring antiplatelet strategies

2 September 2024

Congress Session

Nursing and Allied Professions Investigator Awards

27 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources